The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
The global consumer healthcare market is projected to reach $362.17 billion by 2026, with regulatory compliance becoming crucial for survival. Companies like Doseology Sciences Inc. are focusing on regulatory readiness, partnering with McKinney Regulatory Science Advisors to enhance their market strategies. This partnership aims to navigate FDA requirements and strengthen intellectual property protection. Additionally, Philip Morris is expanding its partnership with Scuderia Ferrari HP, while Celsius Holdings is achieving significant market share growth in the energy drink sector. Regulatory clarity is now a key value driver in the healthcare economy.
MorningStar·
